ScholarLens Back to search
2023•Evidence-based Complementary and Alternative MedicineOpen access

Retracted: Application Value of Combined Detection of Anti‐ β 2‐GPI, ACL, and Lupus Anticoagulant in the Diagnosis of Patients with Antiphospholipid Syndrome

Evidence-Based Complementary and Alternative Medicine

Open full text 0 citations

Abstract

[This retracts the article DOI: 10.1155/2022/9377334.].

Open-access reader

About this research paper

What this paper is about

[This retracts the article DOI: 10.1155/2022/9377334.].

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

[This retracts the article DOI: 10.1155/2022/9377334.].

Key concepts: Antiphospholipid syndrome, Lupus anticoagulant, Medicine, Systemic lupus erythematosus, Value (mathematics), Immunology, Internal medicine, Computer science

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Retracted: Application Value of Combined Detection of Anti‐ β 2‐GPI, ACL, and Lupus Anticoagulant in the Diagnosis of Patients with Antiphospholipid Syndrome — Research Paper | ScholarLens